November is a fantastic month for the life sciences!
Nordic Bioscience's landmark collaboration study on PRO-C6 in NEJM Evidence has received two editorials.
Research published in NEJM Evidence positions Nordic Bioscience’s PRO-C6 as next-generation biomarker assay for trial enrichment in HFpEF
A multi-million deal in Denmark
Counterfeit versions of Nordic Bioscience's PRO-C3 biochemical assay have recently entered circulation globally.
In pursuit of creating value for both partners and Nordic Bioscience
Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Biomarkers for Chronic Diseases
We showcase how the Nordic Bioscience Protein Fingerprint neo-epitope technology provides serological quantification for Extracellular Matrix (ECM) remodeling.
No event found
Please don't hesitate to contact us if you have any questions or other inquiries.